LexaGene Revenue and Competitors
Estimated Revenue & Valuation
- LexaGene's estimated annual revenue is currently $930k per year.
- LexaGene's estimated revenue per employee is $77,500
Employee Data
- LexaGene has 12 Employees.
- LexaGene grew their employee count by -8% last year.
LexaGene's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Director | Reveal Email/Phone |
2 | Manufacturing and Service Supervisor | Reveal Email/Phone |
LexaGene Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $12.7M | 82 | -45% | $107.3M | N/A |
#2 | $0.2M | 1 | -50% | N/A | N/A |
#3 | $6.2M | 40 | 21% | N/A | N/A |
#4 | $42.2M | 218 | 4% | $165M | N/A |
#5 | $14.6M | 94 | -37% | $312.8M | N/A |
#6 | $0.3M | 2 | -67% | N/A | N/A |
#7 | $235M | 366 | -5% | $340.9M | N/A |
#8 | $56M | 289 | -7% | $7.6M | N/A |
#9 | $4.7M | 61 | 36% | N/A | N/A |
#10 | $2M | 13 | 8% | N/A | N/A |
What Is LexaGene?
LexaGene (OTCQB:LXXGF - TSX.V:LXG) is a molecular diagnostics company developing an open-access, fully automated system for rapid and sensitive pathogen detection. MiQLab is PCR-based and can detect up to 27 targets at once for testing in human clinical and veterinary diagnostics, as well as food safety testing, and open-access custom testing markets that need critical answers in less time.
keywords:N/A
N/A
Total Funding
12
Number of Employees
$930k
Revenue (est)
-8%
Employee Growth %
N/A
Valuation
N/A
Accelerator
LexaGene News
LexaGene CEO and founder Dr. Jack Regan said the purchase could be the start of a wave of adoption of MiQLab. Testing in the veterinary...
LexaGene Announces Multi-System Purchase from a Corporate Veterinary Reference Laboratory. April 25, 2022 08:45 ET | Source: LexaGene Holdings Inc LexaGene...
LexaGene's MiQLab® System is designed to process liquid samples from companion animals used in the diagnosis of infections such as urinary...
BEVERLY, Mass. - September 3, 2021 - LexaGene Holdings, Inc. ('the Company'), (OTCQB: LXXGF; TSX-V: LXG), a molecular diagnostics company that develops fully automated rapid pathogen detection systems, today announces that it has filed and received a receipt for a preliminary short form base she ...
BEVERLY, Mass. USA - June 29, 2021 -LexaGene Holdings, Inc., (OTCQB: LXXGF; TSX-V: LXG) (the 'Company'), a molecular diagnostics company that develops fully automated rapid pathogen detection systems, today announced that the Company filed their Annual Information Form and its financial results ...
Other Companies in Beverly
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $1M | 12 | -25% | N/A |
#2 | $1M | 13 | 18% | N/A |
#3 | $2M | 13 | -13% | N/A |
#4 | $2M | 13 | 8% | N/A |
#5 | $1.2M | 14 | 0% | N/A |